Outpatient care of the cystic fibrosis patient after lung transplantation

Current Opinion in Pulmonary Medicine

Volumn 6, Issue 6, 2000, Pages 551-557

  Yankaskas, James R ^a   Aris, Robert ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALENDRONIC ACID; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIBODY; DILTIAZEM; ERGOCALCIFEROL; GANCICLOVIR; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; NIFEDIPINE; NYSTATIN; OMEPRAZOLE; PAMIDRONIC ACID; PHENYTOIN; PREDNISONE; PROTON PUMP INHIBITOR; RANITIDINE; TACROLIMUS; UNINDEXED DRUG;

CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DRUG INDUCED DISEASE; GASTROINTESTINAL TOXICITY; GRAFT REJECTION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; NEPHROTOXICITY; ORGAN TRANSPLANTATION; OSTEOPOROSIS; OUTPATIENT CARE; PATIENT CARE; POSTOPERATIVE INFECTION; REVIEW;

EID: 0033771429     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200011000-00016     Document Type: Review

References (24)

1. Lung transplantation in cystic fibrosis: Consensus conference statement
2. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
3. Lung transplantation and life extension in children with cystic fibrosis
4. Lung transplantation for cystic fibrosis: Effective and durable therapy in a high-risk group
5. Lung transplantation
6. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group
7. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis
8. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients
9. Infectious complications of lung transplantation: Impact of cystic fibrosis
10. Obliterative bronchiolitis after lung transplantation
11. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients
12. Preemptive treatment for the prevention of cytomegalovirus disease: In lung and heart transplant recipients
13. Intestines
14. GI complications after orthotopic lung transplantation
15. Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution
16. The risk of cancer among patients with cystic fibrosis
17. Nutrition
18. Nutrition in the pediatric double lung transplant patient with cystic fibrosis
19. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: A consensus conference report
20. Severe osteoporosis before and after lung transplantation
21. Efficacy of pamidronate for osteoporosis in cystic fibrosis patients following lung transplantation
22. Post-transplantation lymphoproliferative disorder (PTLD) in the EBV-naive lung transplant recipient
23. High incidence of posttransplant lymphoproliferative disease in pediatric patients with cystic fibrosis